Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors
| Image |  |
|---|---|
| Description | scientific article published on 3 November 2012 |
| Author/s |
author: Kazuhiro Shibayama Takatoshi Takubo Nozomu Fuse Toshihiko Doi Makoto Tahara Takayuki Yoshino Atsushi Ohtsu |
| Publication date | November 3, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |